Yuichiro Tanaka, PhD

Title(s)Professor, Urology
SchoolSchool of Medicine
Address4150 Clement St
San Francisco CA 94121
Phone415-750-2031
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Racial differences in CYP1B1 polymorphisms and risks for prostate cancer
    NIH R21CA185003Jul 1, 2015 - Jun 30, 2017
    Role: Principal Investigator
    Role of genetic biomarkers in clinical assessment of prostate cancer
    NIH IP1BX001604Oct 1, 2012 - Sep 30, 2016
    Role: Co-Principal Investigator
    Role of catechol-O-methyltransferase gene in prostate cancer
    NIH I01BX000726Jul 1, 2010 - Mar 31, 2020
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Suppressor effect of catechol-O-methyltransferase gene in prostate cancer. PLoS One. 2021; 16(9):e0253877. Hashimoto Y, Shiina M, Maekawa S, Kato T, Shahryari V, Kulkarni P, Dasgupta P, Yamamura S, Saini S, Tabatabai ZL, Dahiya R, Tanaka Y. PMID: 34587154; PMCID: PMC8480839.
      View in: PubMed   Mentions:    Fields:    
    2. Role of miR-182/PDCD4 axis in aggressive behavior of prostate cancer in the African Americans. BMC Cancer. 2021 Sep 15; 21(1):1028. Shiina M, Hashimoto Y, Kulkarni P, Dasgupta P, Shahryari V, Yamamura S, Tanaka Y, Dahiya R. PMID: 34525952; PMCID: PMC8444584.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. Editor's Note: Epigenetic Modifications of RASSF1A Gene through Chromatin Remodeling in Prostate Cancer. Clin Cancer Res. 2021 05 01; 27(9):2665. Kawamoto K, Okino ST, Place RF, Urakami S, Hirata H, Kikuno N, Kawakami T, Tanaka Y, Pookot D, Chen Z, Majid S, Enokida H, Nakagawa M, Dahiya R. PMID: 33941548.
      View in: PubMed   Mentions:    Fields:    
    4. A lncRNA TCL6-miR-155 Interaction Regulates the Src-Akt-EMT Network to Mediate Kidney Cancer Progression and Metastasis. Cancer Res. 2021 03 15; 81(6):1500-1512. Kulkarni P, Dasgupta P, Hashimoto Y, Shiina M, Shahryari V, Tabatabai ZL, Yamamura S, Tanaka Y, Saini S, Dahiya R, Majid S. PMID: 33500248; PMCID: PMC7969457.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    5. Role of the PI3K/Akt pathway in cadmium induced malignant transformation of normal prostate epithelial cells. Toxicol Appl Pharmacol. 2020 12 15; 409:115308. Kulkarni P, Dasgupta P, Bhat NS, Hashimoto Y, Saini S, Shahryari V, Yamamura S, Shiina M, Tanaka Y, Dahiya R, Majid S. PMID: 33129824; PMCID: PMC7726053.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    6. LncRNA CDKN2B-AS1/miR-141/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma. Cell Death Dis. 2020 08 19; 11(8):660. Dasgupta P, Kulkarni P, Majid S, Hashimoto Y, Shiina M, Shahryari V, Bhat NS, Tabatabai L, Yamamura S, Saini S, Tanaka Y, Dahiya R. PMID: 32814766; PMCID: PMC7438482.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    7. Activation of the Erk/MAPK signaling pathway is a driver for cadmium induced prostate cancer. Toxicol Appl Pharmacol. 2020 08 15; 401:115102. Dasgupta P, Kulkarni P, Bhat NS, Majid S, Shiina M, Shahryari V, Yamamura S, Tanaka Y, Gupta RK, Dahiya R, Hashimoto Y. PMID: 32512071; PMCID: PMC7425797.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    8. Genistein Represses HOTAIR/Chromatin Remodeling Pathways to Suppress Kidney Cancer. Cell Physiol Biochem. 2020 01 22; 54(1):53-70. Imai-Sumida M, Dasgupta P, Kulkarni P, Shiina M, Hashimoto Y, Shahryari V, Majid S, Tanaka Y, Dahiya R, Yamamura S. PMID: 31961100; PMCID: PMC7382546.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    9. BRN4 Is a Novel Driver of Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer and Is Selectively Released in Extracellular Vesicles with BRN2. Clin Cancer Res. 2019 11 01; 25(21):6532-6545. Bhagirath D, Yang TL, Tabatabai ZL, Majid S, Dahiya R, Tanaka Y, Saini S. PMID: 31371344; PMCID: PMC6825556.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    10. Role of a novel race-related tumor suppressor microRNA located in frequently deleted chromosomal locus 8p21 in prostate cancer progression. Carcinogenesis. 2019 07 04; 40(5):633-642. Bhagirath D, Yang TL, Tabatabai ZL, Shahryari V, Majid S, Dahiya R, Tanaka Y, Saini S. PMID: 30874288; PMCID: PMC7331454.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    11. Upregulation of miR-130b Contributes to Risk of Poor Prognosis and Racial Disparity in African-American Prostate Cancer. Cancer Prev Res (Phila). 2019 09; 12(9):585-598. Hashimoto Y, Shiina M, Dasgupta P, Kulkarni P, Kato T, Wong RK, Tanaka Y, Shahryari V, Maekawa S, Yamamura S, Saini S, Deng G, Tabatabai ZL, Majid S, Dahiya R. PMID: 31266828; PMCID: PMC7327781.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    12. Layilin enhances the invasive ability of malignant glioma cells via SNAI1 signaling. Brain Res. 2019 09 15; 1719:140-147. Kaji T, Arito M, Tsutiya A, Sase T, Onodera H, Sato T, Omoteyama K, Sato M, Suematsu N, Kurokawa MS, Tanaka Y, Kato T. PMID: 31145904.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    13. The X-linked tumor suppressor TSPX downregulates cancer-drivers/oncogenes in prostate cancer in a C-terminal acidic domain dependent manner. Oncotarget. 2019 Feb 19; 10(15):1491-1506. Kido T, Li Y, Tanaka Y, Dahiya R, Chris Lau YF. PMID: 30863497; PMCID: PMC6407674.
      View in: PubMed   Mentions: 3     Fields:    
    14. Correction: Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation. Oncotarget. 2018 09 25; 9(75):34190. Chang I, Mitsui Y, Kim SK, Sun JS, Jeon HS, Kang JY, Kang NJ, Fukuhara S, Gill A, Shahryari V, Tabatabai ZL, Greene KL, Dahiya R, Shin DM, Tanaka Y. PMID: 30344932; PMCID: PMC6183339.
      View in: PubMed   Mentions: 1     Fields:    
    15. Influence of lifestyle choices on risks of CYP1B1 polymorphisms for prostate cancer. J Cell Mol Med. 2018 10; 22(10):4676-4687. Kato T, Hashimoto Y, Wong RK, Mitsui Y, Maekawa S, Chang I, Shahryari V, Yamamura S, Majid S, Saini S, Tabatabai ZL, Dahiya R, Deguchi T, Tanaka Y. PMID: 30133114; PMCID: PMC6156244.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    16. Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished MALAT-1 Expression. Mol Cancer Res. 2018 11; 16(11):1750-1760. Kulkarni P, Dasgupta P, Bhat NS, Shahryari V, Shiina M, Hashimoto Y, Majid S, Deng G, Saini S, Tabatabai ZL, Yamamura S, Tanaka Y, Dahiya R. PMID: 30037856; PMCID: PMC6214767.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    17. MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma. Mol Cancer Ther. 2018 05; 17(5):1061-1069. Dasgupta P, Kulkarni P, Majid S, Shahryari V, Hashimoto Y, Bhat NS, Shiina M, Deng G, Saini S, Tabatabai ZL, Yamamura S, Tanaka Y, Dahiya R. PMID: 29440295; PMCID: PMC5932222.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansAnimalsCells
    18. microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer. Cancer Res. 2018 04 01; 78(7):1833-1844. Bhagirath D, Yang TL, Bucay N, Sekhon K, Majid S, Shahryari V, Dahiya R, Tanaka Y, Saini S. PMID: 29437039; PMCID: PMC5890910.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansAnimalsCells
    19. Risk Factors for Helicobacter pylori Infection and Endoscopic Reflux Esophagitis in Healthy Young Japanese Volunteers. Intern Med. 2017 Nov 15; 56(22):2979-2983. Tanaka Y, Sakata Y, Hara M, Kawakubo H, Tsuruoka N, Yamamoto K, Itoh Y, Hidaka H, Shimoda R, Iwakiri R, Fujimoto K. PMID: 28943553; PMCID: PMC5725850.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    20. Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathways. Oncotarget. 2017 Nov 03; 8(54):92032-92042. Imai-Sumida M, Chiyomaru T, Majid S, Saini S, Nip H, Dahiya R, Tanaka Y, Yamamura S. PMID: 29190895; PMCID: PMC5696161.
      View in: PubMed   Mentions: 9     Fields:    
    21. Interaction and cross-talk between non-coding RNAs. Cell Mol Life Sci. 2018 02; 75(3):467-484. Yamamura S, Imai-Sumida M, Tanaka Y, Dahiya R. PMID: 28840253; PMCID: PMC5765200.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansAnimals
    22. MicroRNA-720 Regulates E-cadherin-αE-catenin Complex and Promotes Renal Cell Carcinoma. Mol Cancer Ther. 2017 Dec; 16(12):2840-2848. Bhat NS, Colden M, Dar AA, Saini S, Arora P, Shahryari V, Yamamura S, Tanaka Y, Kato T, Majid S, Dahiya R. PMID: 28802251; PMCID: PMC5893503.
      View in: PubMed   Mentions: 10  Translation:HumansAnimalsCells
    23. Cytochrome P450 1B1 inhibition suppresses tumorigenicity of prostate cancer via caspase-1 activation. Oncotarget. 2017 Jun 13; 8(24):39087-39100. Chang I, Mitsui Y, Kim SK, Sun JS, Jeon HS, Kang JY, Kang NJ, Fukuhara S, Gill A, Shahryari V, Tabatabai ZL, Greene KL, Dahiya R, Shin DM, Tanaka Y. PMID: 28388569; PMCID: PMC5503597.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    24. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition. Cell Death Differ. 2017 07; 24(7):1263-1274. Bucay N, Bhagirath D, Sekhon K, Yang T, Fukuhara S, Majid S, Shahryari V, Tabatabai Z, Greene KL, Hashimoto Y, Shiina M, Yamamura S, Tanaka Y, Deng G, Dahiya R, Saini S. PMID: 28498363; PMCID: PMC5520174.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    25. The role of miR-24 as a race related genetic factor in prostate cancer. Oncotarget. 2017 Mar 07; 8(10):16581-16593. Hashimoto Y, Shiina M, Kato T, Yamamura S, Tanaka Y, Majid S, Saini S, Shahryari V, Kulkarni P, Dasgupta P, Mitsui Y, Sumida M, Deng G, Tabatabai L, Kumar D, Dahiya R. PMID: 28157714; PMCID: PMC5369986.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    26. Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma. Mol Cancer Res. 2017 07; 15(7):884-895. Mitsui Y, Shiina H, Kato T, Maekawa S, Hashimoto Y, Shiina M, Imai-Sumida M, Kulkarni P, Dasgupta P, Wong RK, Hiraki M, Arichi N, Fukuhara S, Yamamura S, Majid S, Saini S, Deng G, Dahiya R, Nakajima K, Tanaka Y. PMID: 28242813; PMCID: PMC5890926.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    27. Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians. Oncotarget. 2017 Jan 31; 8(5):8356-8368. Shiina M, Hashimoto Y, Kato T, Yamamura S, Tanaka Y, Majid S, Saini S, Varahram S, Kulkarni P, Dasgupta P, Mitsui Y, Sumida M, Tabatabai L, Deng G, Kumar D, Dahiya R. PMID: 28039468; PMCID: PMC5352406.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    28. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2. Cell Death Dis. 2017 01 26; 8(1):e2572. Colden M, Dar AA, Saini S, Dahiya PV, Shahryari V, Yamamura S, Tanaka Y, Stein G, Dahiya R, Majid S. PMID: 28125091; PMCID: PMC5386393.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansAnimalsCells
    29. Hypoxia-induced production of peptidylarginine deiminases and citrullinated proteins in malignant glioma cells. Biochem Biophys Res Commun. 2017 Jan 01; 482(1):50-56. Sase T, Arito M, Onodera H, Omoteyama K, Kurokawa MS, Kagami Y, Ishigami A, Tanaka Y, Kato T. PMID: 27818200.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    30. Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates epidermal growth factor receptor in prostate cancer. Oncotarget. 2016 Oct 25; 7(43):70388-70403. Bucay N, Sekhon K, Majid S, Yamamura S, Shahryari V, Tabatabai ZL, Greene K, Tanaka Y, Dahiya R, Deng G, Saini S. PMID: 27611943; PMCID: PMC5342560.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    31. Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer. Oncotarget. 2016 Oct 18; 7(42):68371-68384. Nip H, Dar AA, Saini S, Colden M, Varahram S, Chowdhary H, Yamamura S, Mitsui Y, Tanaka Y, Kato T, Hashimoto Y, Shiina M, Kulkarni P, Dasgupta P, Imai-Sumida M, Tabatabai ZL, Greene K, Deng G, Dahiya R, Majid S. PMID: 27634912; PMCID: PMC5356562.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    32. Pre-clinical Orthotopic Murine Model of Human Prostate Cancer. J Vis Exp. 2016 Aug 29; (114). Shahryari V, Nip H, Saini S, Dar AA, Yamamura S, Mitsui Y, Colden M, Bucay N, Tabatabai LZ, Greene K, Deng G, Tanaka Y, Dahiya R, Majid S. PMID: 27684100; PMCID: PMC5091966.
      View in: PubMed   Mentions: 1     Fields:    
    33. Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer. Oncotarget. 2016 Aug 02; 7(31):49107-49121. Mitsui Y, Chang I, Kato T, Hashimoto Y, Yamamura S, Fukuhara S, Wong DK, Shiina M, Imai-Sumida M, Majid S, Saini S, Shiina H, Nakajima K, Deng G, Dahiya R, Tanaka Y. PMID: 27203547; PMCID: PMC5226494.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    34. Relationship Between Muscle Dissection Method and Postoperative Muscle Atrophy in the Lateral Suboccipital Approach to Vestibular Schwannoma Surgery. World Neurosurg. 2016 Oct; 94:426-431. Ogiwara T, Goto T, Aoyama T, Hara Y, Nagm A, Tanaka Y, Hongo K. PMID: 27450979.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    35. Upper Gastrointestinal Symptoms Are More Frequent in Female than Male Young Healthy Japanese Volunteers as Evaluated by Questionnaire. J Neurogastroenterol Motil. 2016 Apr 30; 22(2):248-53. Kawakubo H, Tanaka Y, Tsuruoka N, Hara M, Yamamoto K, Hidaka H, Sakata Y, Shimoda R, Iwakiri R, Kusano M, Fujimoto K. PMID: 26755685; PMCID: PMC4819863.
      View in: PubMed   Mentions: 9  
    36. CYP1B1 promotes tumorigenesis via altered expression of CDC20 and DAPK1 genes in renal cell carcinoma. BMC Cancer. 2015 Dec 01; 15:942. Mitsui Y, Chang I, Fukuhara S, Hiraki M, Arichi N, Yasumoto H, Hirata H, Yamamura S, Shahryari V, Deng G, Wong DK, Majid S, Shiina H, Dahiya R, Tanaka Y. PMID: 26626260; PMCID: PMC4665921.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    37. miRNA Expression Analyses in Prostate Cancer Clinical Tissues. J Vis Exp. 2015 Sep 08; (103). Bucay N, Shahryari V, Majid S, Yamamura S, Mitsui Y, Tabatabai ZL, Greene K, Deng G, Dahiya R, Tanaka Y, Saini S. PMID: 26382040; PMCID: PMC4692597.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    38. Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells. Oncotarget. 2015 Jun 30; 6(18):16341-51. Fukuhara S, Chang I, Mitsui Y, Chiyomaru T, Yamamura S, Majid S, Saini S, Deng G, Gill A, Wong DK, Shiina H, Nonomura N, Lau YF, Dahiya R, Tanaka Y. PMID: 26036629; PMCID: PMC4599273.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    39. Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways. Oncotarget. 2015 Apr 20; 6(11):9577-91. Mitsui Y, Hirata H, Arichi N, Hiraki M, Yasumoto H, Chang I, Fukuhara S, Yamamura S, Shahryari V, Deng G, Saini S, Majid S, Dahiya R, Tanaka Y, Shiina H. PMID: 25797254; PMCID: PMC4496240.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    40. Loss of miR-200c up-regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma. Oncotarget. 2015 Apr 10; 6(10):7774-87. Chang I, Mitsui Y, Fukuhara S, Gill A, Wong DK, Yamamura S, Shahryari V, Tabatabai ZL, Dahiya R, Shin DM, Tanaka Y. PMID: 25860934; PMCID: PMC4480715.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    41. Versican is a potential therapeutic target in docetaxel-resistant prostate cancer. Oncoscience. 2015; 2(2):193-204. Arichi N, Mitsui Y, Hiraki M, Nakamura S, Hiraoka T, Sumura M, Hirata H, Tanaka Y, Dahiya R, Yasumoto H, Shiina H. PMID: 25859560; PMCID: PMC4381710.
      View in: PubMed   Mentions: 8  
    42. DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells. Oncotarget. 2014 Nov 30; 5(22):11297-307. Fukuhara S, Chang I, Mitsui Y, Chiyomaru T, Yamamura S, Majid S, Saini S, Hirata H, Deng G, Gill A, Wong DK, Shiina H, Nonomura N, Dahiya R, Tanaka Y. PMID: 25526032; PMCID: PMC4294331.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    43. Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men. Tumour Biol. 2014 Oct; 35(10):10223-30. Chang I, Fukuhara S, Wong DK, Gill A, Mitsui Y, Majid S, Saini S, Yamamura S, Chiyomaru T, Hirata H, Ueno K, Arora S, Shahryari V, Deng G, Tabatabai ZL, Greene KL, Shin DM, Enokida H, Shiina H, Nonomura N, Dahiya R, Tanaka Y. PMID: 25027399.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    44. Regulation of SRC kinases by microRNA-3607 located in a frequently deleted locus in prostate cancer. Mol Cancer Ther. 2014 Jul; 13(7):1952-63. Saini S, Majid S, Shahryari V, Tabatabai ZL, Arora S, Yamamura S, Tanaka Y, Dahiya R, Deng G. PMID: 24817628; PMCID: PMC4351861.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    45. Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor. Oncotarget. 2014 Apr 30; 5(8):2198-207. Mitsui Y, Yasumoto H, Nagami T, Hiraki M, Arichi N, Ishikawa N, Araki A, Maruyama R, Tanaka Y, Dahiya R, Shiina H. PMID: 24755523; PMCID: PMC4039156.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    46. Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells. J Biol Chem. 2014 May 02; 289(18):12550-65. Chiyomaru T, Fukuhara S, Saini S, Majid S, Deng G, Shahryari V, Chang I, Tanaka Y, Enokida H, Nakagawa M, Dahiya R, Yamamura S. PMID: 24616104; PMCID: PMC4007447.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansCells
    47. Combining molecular targeted drugs to inhibit both cancer cells and activated stromal cells in gastric cancer. Neoplasia. 2013 Dec; 15(12):1391-9. Onoyama M, Kitadai Y, Tanaka Y, Yuge R, Shinagawa K, Tanaka S, Yasui W, Chayama K. PMID: 24403861; PMCID: PMC3884530.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    48. MicroRNA-4723 inhibits prostate cancer growth through inactivation of the Abelson family of nonreceptor protein tyrosine kinases. PLoS One. 2013; 8(11):e78023. Arora S, Saini S, Fukuhara S, Majid S, Shahryari V, Yamamura S, Chiyomaru T, Deng G, Tanaka Y, Dahiya R. PMID: 24223753; PMCID: PMC3815229.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    49. Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR. PLoS One. 2013; 8(8):e70372. Chiyomaru T, Yamamura S, Fukuhara S, Yoshino H, Kinoshita T, Majid S, Saini S, Chang I, Tanaka Y, Enokida H, Seki N, Nakagawa M, Dahiya R. PMID: 23936419; PMCID: PMC3731248.
      View in: PubMed   Mentions: 105     Fields:    Translation:HumansCells
    50. MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer. PLoS One. 2013; 8(7):e67686. Majid S, Dar AA, Saini S, Deng G, Chang I, Greene K, Tanaka Y, Dahiya R, Yamamura S. PMID: 23844063; PMCID: PMC3699593.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCells
    51. Hrk mediates 2-methoxyestradiol-induced mitochondrial apoptotic signaling in prostate cancer cells. Mol Cancer Ther. 2013 Jun; 12(6):1049-59. Chang I, Majid S, Saini S, Zaman MS, Yamamura S, Chiyomaru T, Shahryari V, Fukuhara S, Deng G, Dahiya R, Tanaka Y. PMID: 23580416.
      View in: PubMed   Mentions: 7  Translation:HumansCells
    52. Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer. PLoS One. 2013; 8(3):e58929. Chiyomaru T, Yamamura S, Fukuhara S, Hidaka H, Majid S, Saini S, Arora S, Deng G, Shahryari V, Chang I, Tanaka Y, Tabatabai ZL, Enokida H, Seki N, Nakagawa M, Dahiya R. PMID: 23554959; PMCID: PMC3595226.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansAnimalsCells
    53. MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PLoS One. 2013; 8(1):e55502. Hirata H, Ueno K, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL, Hinoda Y, Dahiya R. PMID: 23383207; PMCID: PMC3559583.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansAnimalsCells
    54. Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer. PLoS One. 2012; 7(11):e51056. Hirata H, Ueno K, Shahryari V, Tanaka Y, Tabatabai ZL, Hinoda Y, Dahiya R. PMID: 23226455; PMCID: PMC3511415.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    55. Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer. PLoS One. 2012; 7(11):e50203. Zaman MS, Thamminana S, Shahryari V, Chiyomaru T, Deng G, Saini S, Majid S, Fukuhara S, Chang I, Arora S, Hirata H, Ueno K, Singh K, Tanaka Y, Dahiya R. PMID: 23189187; PMCID: PMC3506541.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    56. miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways. Clin Cancer Res. 2013 Jan 01; 19(1):73-84. Majid S, Dar AA, Saini S, Shahryari V, Arora S, Zaman MS, Chang I, Yamamura S, Tanaka Y, Chiyomaru T, Deng G, Dahiya R. PMID: 23147995; PMCID: PMC3910324.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    57. miR-23b represses proto-oncogene Src kinase and functions as methylation-silenced tumor suppressor with diagnostic and prognostic significance in prostate cancer. Cancer Res. 2012 Dec 15; 72(24):6435-46. Majid S, Dar AA, Saini S, Arora S, Shahryari V, Zaman MS, Chang I, Yamamura S, Tanaka Y, Deng G, Dahiya R. PMID: 23074286; PMCID: PMC3940348.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansAnimalsCells
    58. MicroRNA-1280 inhibits invasion and metastasis by targeting ROCK1 in bladder cancer. PLoS One. 2012; 7(10):e46743. Majid S, Dar AA, Saini S, Shahryari V, Arora S, Zaman MS, Chang I, Yamamura S, Chiyomaru T, Fukuhara S, Tanaka Y, Deng G, Tabatabai ZL, Dahiya R. PMID: 23056431; PMCID: PMC3464246.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    59. Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151. PLoS One. 2012; 7(8):e43812. Chiyomaru T, Yamamura S, Zaman MS, Majid S, Deng G, Shahryari V, Saini S, Hirata H, Ueno K, Chang I, Tanaka Y, Tabatabai ZL, Enokida H, Nakagawa M, Dahiya R. PMID: 22928040; PMCID: PMC3426544.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    60. Endoscopic reflux esophagitis and Helicobacter pylori infection in young healthy Japanese volunteers. Digestion. 2012; 86(1):55-8. Takashima T, Iwakiri R, Sakata Y, Yamaguchi D, Tsuruoka N, Akutagawa K, Komatsu-Tanaka M, Higuchi T, Tanaka Y, Shimoda R, Sakata H, Kawakubo M, Oda Y, Fujimoto K. PMID: 22722701.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    61. miRNA-708 control of CD44(+) prostate cancer-initiating cells. Cancer Res. 2012 Jul 15; 72(14):3618-30. Saini S, Majid S, Shahryari V, Arora S, Yamamura S, Chang I, Zaman MS, Deng G, Tanaka Y, Dahiya R. PMID: 22552290.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansAnimalsCells
    62. Analysis of intracranial pressure pulse waveform and brain capillary morphology in type 2 diabetes mellitus rats. Brain Res. 2012 Jun 15; 1460:73-7. Onodera H, Oshio K, Uchida M, Tanaka Y, Hashimoto T. PMID: 22583857.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    63. Up-regulation of microRNA-21 correlates with lower kidney cancer survival. PLoS One. 2012; 7(2):e31060. Zaman MS, Shahryari V, Deng G, Thamminana S, Saini S, Majid S, Chang I, Hirata H, Ueno K, Yamamura S, Singh K, Tanaka Y, Tabatabai ZL, Dahiya R. PMID: 22347428; PMCID: PMC3275568.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansAnimalsCells
    64. MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma. Carcinogenesis. 2012 Feb; 33(2):294-300. Yamamura S, Saini S, Majid S, Hirata H, Ueno K, Chang I, Tanaka Y, Gupta A, Dahiya R. PMID: 22159222; PMCID: PMC3271269.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    65. Catechol-O-methyltransferase-mediated metabolism of 4-hydroxyestradiol inhibits the growth of human renal cancer cells through the apoptotic pathway. Carcinogenesis. 2012 Feb; 33(2):420-6. Chang I, Liu J, Majid S, Saini S, Zaman MS, Yamamura S, Shahryari V, Chiyomaru T, Deng G, Dahiya R, Tanaka Y. PMID: 22159223.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    66. MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res. 2011 Oct 01; 71(19):6208-19. Saini S, Yamamura S, Majid S, Shahryari V, Hirata H, Tanaka Y, Dahiya R. PMID: 21852381; PMCID: PMC3940359.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansAnimalsCells
    67. MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer. Carcinogenesis. 2011 May; 32(5):772-8. Suh SO, Chen Y, Zaman MS, Hirata H, Yamamura S, Shahryari V, Liu J, Tabatabai ZL, Kakar S, Deng G, Tanaka Y, Dahiya R. PMID: 21349819; PMCID: PMC3086703.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansCells
    68. MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer. Cancer Res. 2011 Apr 01; 71(7):2611-21. Majid S, Saini S, Dar AA, Hirata H, Shahryari V, Tanaka Y, Yamamura S, Ueno K, Zaman MS, Singh K, Chang I, Deng G, Dahiya R. PMID: 21330408; PMCID: PMC3940352.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    69. Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer. Int J Cancer. 2011 Feb 01; 128(3):541-50. Kawakami K, Yamamura S, Hirata H, Ueno K, Saini S, Majid S, Tanaka Y, Kawamoto K, Enokida H, Nakagawa M, Dahiya R. PMID: 20340127; PMCID: PMC3940353.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    70. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Clin Cancer Res. 2011 Aug 15; 17(16):5287-98. Saini S, Majid S, Yamamura S, Tabatabai L, Suh SO, Shahryari V, Chen Y, Deng G, Tanaka Y, Dahiya R. PMID: 21159887.
      View in: PubMed   Mentions: 132     Fields:    Translation:HumansAnimalsCells
    71. MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer. Cancer Prev Res (Phila). 2011 Jan; 4(1):76-86. Chen Y, Zaman MS, Deng G, Majid S, Saini S, Liu J, Tanaka Y, Dahiya R. PMID: 21071579; PMCID: PMC3894108.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    72. MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer. 2010 Dec 15; 116(24):5637-49. Majid S, Dar AA, Saini S, Yamamura S, Hirata H, Tanaka Y, Deng G, Dahiya R. PMID: 20737563; PMCID: PMC3940365.
      View in: PubMed   Mentions: 108     Fields:    Translation:HumansCells
    73. Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. Cancer Res. 2010 Apr 01; 70(7):2809-18. Majid S, Dar AA, Saini S, Chen Y, Shahryari V, Liu J, Zaman MS, Hirata H, Yamamura S, Ueno K, Tanaka Y, Dahiya R. PMID: 20332239.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCells
    74. Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer. Cancer. 2010 Jan 01; 116(1):66-76. Majid S, Dar AA, Shahryari V, Hirata H, Ahmad A, Saini S, Tanaka Y, Dahiya AV, Dahiya R. PMID: 19885928; PMCID: PMC3954042.
      View in: PubMed   Mentions: 64     Fields:    Translation:HumansCells
    75. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer. Cancer Res. 2009 Nov 15; 69(22):8603-10. Kawakami K, Hirata H, Yamamura S, Kikuno N, Saini S, Majid S, Tanaka Y, Kawamoto K, Enokida H, Nakagawa M, Dahiya R. PMID: 19887605.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    76. Polymorphisms of MLH1 in benign prostatic hyperplasia and sporadic prostate cancer. Biochem Biophys Res Commun. 2009 Jun 12; 383(4):440-4. Tanaka Y, Zaman MS, Majid S, Liu J, Kawakami K, Shiina H, Tokizane T, Dahiya AV, Sen S, Nakajima K. PMID: 19364498.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    77. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis. 2009 Apr; 30(4):662-70. Majid S, Dar AA, Ahmad AE, Hirata H, Kawakami K, Shahryari V, Saini S, Tanaka Y, Dahiya AV, Khatri G, Dahiya R. PMID: 19221000; PMCID: PMC2664457.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCells
    78. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Int J Cancer. 2008 Aug 01; 123(3):535-42. Kawamoto K, Hirata H, Kikuno N, Tanaka Y, Nakagawa M, Dahiya R. PMID: 18404682.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    79. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int J Cancer. 2008 Aug 01; 123(3):552-60. Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y, Majid S, Igawa M, Dahiya R. PMID: 18431742.
      View in: PubMed   Mentions: 80     Fields:    Translation:HumansCells
    80. Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res. 2008 Apr 15; 68(8):2736-44. Majid S, Kikuno N, Nelles J, Noonan E, Tanaka Y, Kawamoto K, Hirata H, Li LC, Zhao H, Okino ST, Place RF, Pookot D, Dahiya R. PMID: 18413741.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCells
    81. Mismatch repair gene MSH3 polymorphism is associated with the risk of sporadic prostate cancer. J Urol. 2008 May; 179(5):2020-4. Hirata H, Hinoda Y, Kawamoto K, Kikuno N, Suehiro Y, Okayama N, Tanaka Y, Dahiya R. PMID: 18355840; PMCID: PMC3940351.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    82. Analysis of immunohistochemical expression of p53 and the proliferation marker Ki-67 antigen in skull base chordomas: relationships between their expression and prognosis. Brain Tumor Pathol. 2007; 24(2):57-62. Sakai K, Hongo K, Tanaka Y, Nakayama J. PMID: 18095132.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    83. CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility. Clin Cancer Res. 2007 Sep 01; 13(17):5056-62. Hirata H, Hinoda Y, Kikuno N, Kawamoto K, Dahiya AV, Suehiro Y, Tanaka Y, Dahiya R. PMID: 17785557.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    84. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma. Clin Cancer Res. 2007 Jul 15; 13(14):4123-9. Hirata H, Hinoda Y, Kikuno N, Kawamoto K, Suehiro Y, Tanaka Y, Dahiya R. PMID: 17634539.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    85. Enhancement of intracellular gamma-tocopherol levels in cytokine-stimulated C3H 10T1/2 fibroblasts: relation to NO synthesis, isoprostane formation, and tocopherol oxidation. BMC Chem Biol. 2007 Jul 03; 7:2. Tanaka Y, Wood LA, Cooney RV. PMID: 17608946; PMCID: PMC1931582.
      View in: PubMed   Mentions: 10  
    86. Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer. Clin Cancer Res. 2007 May 01; 13(9):2541-8. Kawamoto K, Okino ST, Place RF, Urakami S, Hirata H, Kikuno N, Kawakami T, Tanaka Y, Pookot D, Chen Z, Majid S, Enokida H, Nakagawa M, Dahiya R. PMID: 17473182.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    87. Polymorphisms of catechol-O-methyltransferase in men with renal cell cancer. Cancer Epidemiol Biomarkers Prev. 2007 Jan; 16(1):92-7. Tanaka Y, Hirata H, Chen Z, Kikuno N, Kawamoto K, Majid S, Tokizane T, Urakami S, Shiina H, Nakajima K, Dhir R, Dahiya R. PMID: 17220335.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    88. Polymorphisms of DNA repair genes are risk factors for prostate cancer. Eur J Cancer. 2007 Jan; 43(2):231-7. Hirata H, Hinoda Y, Tanaka Y, Okayama N, Suehiro Y, Kawamoto K, Kikuno N, Majid S, Vejdani K, Dahiya R. PMID: 17196815.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    89. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA. Clin Cancer Res. 2006 Dec 01; 12(23):6989-97. Urakami S, Shiina H, Enokida H, Hirata H, Kawamoto K, Kawakami T, Kikuno N, Tanaka Y, Majid S, Nakagawa M, Igawa M, Dahiya R. PMID: 17145819.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    90. Inhibition of transcellular tumor cell migration and metastasis by novel carba-derivatives of cyclic phosphatidic acid. Biochim Biophys Acta. 2007 Jan; 1771(1):103-12. Uchiyama A, Mukai M, Fujiwara Y, Kobayashi S, Kawai N, Murofushi H, Inoue M, Enoki S, Tanaka Y, Niki T, Kobayashi T, Tigyi G, Murakami-Murofushi K. PMID: 17123862; PMCID: PMC3446789.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    91. The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men. J Urol. 2006 Aug; 176(2):793-6. Pookot D, Li LC, Tabatabai ZL, Tanaka Y, Greene KL, Dahiya R. PMID: 16813949.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    92. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin Cancer Res. 2006 Apr 01; 12(7 Pt 1):2109-16. Urakami S, Shiina H, Enokida H, Kawakami T, Kawamoto K, Hirata H, Tanaka Y, Kikuno N, Nakagawa M, Igawa M, Dahiya R. PMID: 16609023.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    93. Polymorphisms of DNA repair genes are associated with renal cell carcinoma. Biochem Biophys Res Commun. 2006 Apr 21; 342(4):1058-62. Hirata H, Hinoda Y, Matsuyama H, Tanaka Y, Okayama N, Suehiro Y, Zhao H, Urakami S, Kawamoto K, Kawakami T, Igawa M, Naito K, Dahiya R. PMID: 16510122.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    94. Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006 Feb; 15(2):238-44. Tanaka Y, Sasaki M, Shiina H, Tokizane T, Deguchi M, Hirata H, Hinoda Y, Okayama N, Suehiro Y, Urakami S, Kawakami T, Kaneuchi M, Pookot D, Igawa M, Okuyama A, Ishii N, Dahiya R. PMID: 16492910.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    95. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res. 2006 Jan 15; 12(2):383-91. Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA, Terashima M, Kikuno N, Adachi H, Yoneda T, Kishi H, Shigeno K, Konety BR, Igawa M, Dahiya R. PMID: 16428476.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCells
    96. WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma. Cancer. 2005 Nov 01; 104(9):1924-30. Kaneuchi M, Sasaki M, Tanaka Y, Shiina H, Yamada H, Yamamoto R, Sakuragi N, Enokida H, Verma M, Dahiya R. PMID: 16134181.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    97. Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res. 2005 Aug 15; 11(16):5793-801. Tokizane T, Shiina H, Igawa M, Enokida H, Urakami S, Kawakami T, Ogishima T, Okino ST, Li LC, Tanaka Y, Nonomura N, Okuyama A, Dahiya R. PMID: 16115918.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    98. CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer. Cancer. 2005 Jul 01; 104(1):44-52. Zhao H, Shiina H, Greene KL, Li LC, Tanaka Y, Kishi H, Igawa M, Kane CJ, Carroll P, Dahiya R. PMID: 15895377.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    99. Vascular endothelial growth factor restores erectile function through inhibition of apoptosis in diabetic rat penile crura. J Urol. 2005 Jan; 173(1):318-23. Yamanaka M, Shirai M, Shiina H, Tanaka Y, Enokida H, Tsujimura A, Matsumiya K, Okuyama A, Dahiya R. PMID: 15592104.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    100. Expression and methylation status of 14-3-3 sigma gene can characterize the different histological features of ovarian cancer. Biochem Biophys Res Commun. 2004 Apr 16; 316(4):1156-62. Kaneuchi M, Sasaki M, Tanaka Y, Shiina H, Verma M, Ebina Y, Nomura E, Yamamoto R, Sakuragi N, Dahiya R. PMID: 15044106.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    101. Polymorphisms of the CYP1B1 gene as risk factors for human renal cell cancer. Clin Cancer Res. 2004 Mar 15; 10(6):2015-9. Sasaki M, Tanaka Y, Okino ST, Nomoto M, Yonezawa S, Nakagawa M, Fujimoto S, Sakuragi N, Dahiya R. PMID: 15041720.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    102. Resveratrol suppresses growth of Ishikawa cells through down-regulation of EGF. Int J Oncol. 2003 Oct; 23(4):1167-72. Kaneuchi M, Sasaki M, Tanaka Y, Yamamoto R, Sakuragi N, Dahiya R. PMID: 12964000.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    103. Six polymorphisms on estrogen receptor 1 gene in Japanese, American and German populations. Eur J Clin Pharmacol. 2003 Sep; 59(5-6):389-93. Sasaki M, Tanaka Y, Sakuragi N, Dahiya R. PMID: 12923601.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    104. Polymorphisms of estrogen receptor alpha in prostate cancer. Mol Carcinog. 2003 Aug; 37(4):202-8. Tanaka Y, Sasaki M, Kaneuchi M, Shiina H, Igawa M, Dahiya R. PMID: 12891629.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    105. CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor alpha and estrogen receptor beta expressions. Cancer Res. 2003 Jul 15; 63(14):3913-8. Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N, Dahiya R. PMID: 12873984.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    106. Diabetes induced erectile dysfunction and apoptosis in penile crura are recovered by insulin treatment in rats. J Urol. 2003 Jul; 170(1):291-7. Yamanaka M, Shirai M, Shiina H, Tanaka Y, Tsujimura A, Matsumiya K, Okuyama A, Dahiya R. PMID: 12796708.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    107. Alleles of polymorphic sites that correspond to hyperactive variants of CYP1B1 protein are significantly less frequent in Japanese as compared to American and German populations. Hum Mutat. 2003 Jun; 21(6):652. Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N, Dahiya R. PMID: 14961553.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    108. Hypermethylation can selectively silence multiple promoters of steroid receptors in cancers. Mol Cell Endocrinol. 2003 Apr 28; 202(1-2):201-7. Sasaki M, Kaneuchi M, Fujimoto S, Tanaka Y, Dahiya R. PMID: 12770752.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    109. Estrogen receptor alpha polymorphisms and renal cell carcinoma--a possible risk. Mol Cell Endocrinol. 2003 Apr 28; 202(1-2):109-16. Tanaka Y, Sasaki M, Kaneuchi M, Fujimoto S, Dahiya R. PMID: 12770739.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    110. CYP1B1 gene in endometrial cancer. Mol Cell Endocrinol. 2003 Apr 28; 202(1-2):171-6. Sasaki M, Kaneuchi M, Fujimoto S, Tanaka Y, Dahiya R. PMID: 12770747.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    111. Quercetin regulates growth of Ishikawa cells through the suppression of EGF and cyclin D1. Int J Oncol. 2003 Jan; 22(1):159-64. Kaneuchi M, Sasaki M, Tanaka Y, Sakuragi N, Fujimoto S, Dahiya R. PMID: 12469199.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    112. Loss of anti-apoptotic genes in aging rat crura. J Urol. 2002 Nov; 168(5):2296-300. Yamanaka M, Shirai M, Shiina H, Shirai M, Tanaka Y, Fujime M, Okuyama A, Dahiya R. PMID: 12394778.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    113. Polymorphisms of estrogen receptor alpha gene in endometrial cancer. Biochem Biophys Res Commun. 2002 Sep 27; 297(3):558-64. Sasaki M, Tanaka Y, Kaneuchi M, Sakuragi N, Dahiya R. PMID: 12270131.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    114. Single nucleotide polymorphisms of estrogen receptor alpha in human renal cell carcinoma. Biochem Biophys Res Commun. 2002 Sep 06; 296(5):1200-6. Tanaka Y, Sasaki M, Kaneuchi M, Fujimoto S, Dahiya R. PMID: 12207901.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    115. Polymorphisms of the CYP1B1 gene have higher risk for prostate cancer. Biochem Biophys Res Commun. 2002 Aug 30; 296(4):820-6. Tanaka Y, Sasaki M, Kaneuchi M, Shiina H, Igawa M, Dahiya R. PMID: 12200121.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    116. Transforming growth factor-beta(s) and their receptors in aging rat prostate. Biochem Biophys Res Commun. 2002 Jun 07; 294(2):464-9. Zhao H, Patra A, Tanaka Y, Li LC, Dahiya R. PMID: 12051734.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    117. Disturbed spatial learning of rats after intraventricular administration of transforming growth factor-beta 1. Neurol Med Chir (Tokyo). 2002 Apr; 42(4):151-6; discussion 157. Nakazato F, Tada T, Sekiguchi Y, Murakami K, Yanagisawa S, Tanaka Y, Hongo K. PMID: 12013666.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    118. Effects of aging on growth factors gene and protein expression in the dorsal and ventral lobes of rat prostate. Biochem Biophys Res Commun. 2002 Mar 29; 292(2):482-91. Zhao H, Patra A, Yeh CC, Tanaka Y, Oh BR, Dahiya R. PMID: 11906188.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    119. Methylation and inactivation of estrogen, progesterone, and androgen receptors in prostate cancer. J Natl Cancer Inst. 2002 Mar 06; 94(5):384-90. Sasaki M, Tanaka Y, Perinchery G, Dharia A, Kotcherguina I, Fujimoto Si, Dahiya R. PMID: 11880477.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    120. Inhibition of colonic aberrant crypt formation by the dietary flavonoids (+)-catechin and hesperidin. Adv Exp Med Biol. 2002; 505:123-33. Franke AA, Custer LJ, Cooney RV, Tanaka Y, Xu M, Dashwood RH. PMID: 12083456.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    Yuichiro's Networks
    Concepts (471)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (8)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB02.

    Copyright © The Regents of the University of California